About Shimonoseki City Hospital
地方独立行政法人下関市立市民病院は、山口県下関市向洋町にある病院。災害拠点病院及び地域医療支援病院に指定されている。
Clinical Trials at Shimonoseki City Hospital
During the past decade, Shimonoseki City Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Shimonoseki City Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials
sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Janssen Pharmaceutical K.K."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Shimonoseki City Hospital"
#1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Shimonoseki City Hospital
According to Clinical.Site data, the most researched conditions in "Shimonoseki City Hospital" are
"Colorectal Cancer" (2 trials), "Low Back Pain" (2 trials), "Central Nervous System Diseases" (1 trials), "Chronic Cough" (1 trials) and "Diagnostic Imaging" (1 trials). Many other conditions were trialed in "Shimonoseki City Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Shimonoseki City Hospital
Most popular intervention types in "Shimonoseki City Hospital" are "Drug" (7 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "UFT adjuvant chemotherapy" (2 trials), "Bedaquiline" (1 trials), "Celecoxib" (1 trials) and "Clarithromycin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Shimonoseki City Hospital
The vast majority of trials in "Shimonoseki City Hospital" are
10 trials for "All" genders.
Clinical Trials Status at Shimonoseki City Hospital
Currently, there are NaN active trials in "Shimonoseki City Hospital".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Shimonoseki City Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Shimonoseki City Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".